EuroPCR 2017: Xeltis' Regenerated Heart Valve Shows Promising Early Preclinical Data

 
• By Catherine Longworth
  
Anatomy of Human Heart
Xeltis presented positive early data from preclinical studies at EuroPCR in Paris • Source: Shutterstock
Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

SpotifyApple PodcastsWebsite

More from Startups & SMEs

More from Business